Protein misfolding and disease; protein refolding and therapy

被引:273
作者
Soto, C [1 ]
机构
[1] Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
关键词
protein conformational disorders; amyloid; protein misfolding; therapy; beta-sheet breaker peptides;
D O I
10.1016/S0014-5793(01)02486-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diverse human disorders, including several neurodegenerative diseases and systemic amyloidosis, are thought to arise from the misfolding and aggregation of an underlying protein, Recent findings strongly support this hypothesis and have increased our understanding of the molecular mechanism of protein conformational disorders. Many questions are still pending, but the data overall suggest that correction of protein misfolding constitutes a viable therapeutic strategy for conformational diseases, (C) 2001 Federation of European Biochemical Societies, Published by Elsevier Science B,V, All rights reserved.
引用
收藏
页码:204 / 207
页数:4
相关论文
共 35 条
[21]  
Price DL, 1997, REV NEUROL-FRANCE, V153, P484
[22]   Prions [J].
Prusiner, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13363-13383
[23]   Transgenic models of Huntington's disease [J].
Sathasivam, K ;
Hobbs, C ;
Mangiarini, L ;
Mahal, A ;
Turmaine, M ;
Doherty, P ;
Davies, SW ;
Bates, GP .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1386) :963-969
[24]   EXAMINATION OF THE STRUCTURE OF THE TRANSTHYRETIN AMYLOID FIBRIL BY IMAGE-RECONSTRUCTION FROM ELECTRON-MICROGRAPHS [J].
SERPELL, LC ;
SUNDE, M ;
FRASER, PE ;
LUTHER, PK ;
MORRIS, EP ;
SANGREN, O ;
LUNDGREN, E ;
BLAKE, CCF .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 254 (02) :113-118
[25]   DEFECTIVE PROTEIN-FOLDING AS A CAUSE OF DISEASE [J].
SIFERS, RN .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (05) :355-357
[26]   In vivo reversal of amyloid-β lesions in rat brain [J].
Sigurdsson, EM ;
Permanne, B ;
Soto, C ;
Wisniewski, T ;
Frangione, B .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (01) :11-17
[27]   Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches [J].
Soto, C .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (05) :412-418
[28]   β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis:: Implications for Alzheimer's therapy [J].
Soto, C ;
Sigurdsson, EM ;
Morelli, L ;
Kumar, RA ;
Castano, EM ;
Frangione, B .
NATURE MEDICINE, 1998, 4 (07) :822-826
[29]   Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides [J].
Soto, C ;
Kascsak, RJ ;
Saborío, GP ;
Aucouturier, P ;
Wisniewski, T ;
Prelli, F ;
Kascsak, R ;
Mendez, E ;
Harris, DA ;
Ironside, J ;
Tagliavini, F ;
Carp, RI ;
Frangione, B .
LANCET, 2000, 355 (9199) :192-197
[30]   β-amyloid disrupting drugs -: Potential in the treatment of Alzheimer's disease [J].
Soto, C .
CNS DRUGS, 1999, 12 (05) :347-356